Phil Gutry

Insider Reports History

Entity
Individual
Location
400 E. Pratt Street, Suite 606, Baltimore, MD
Signature
/s/ Zed Zduniak, attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Phil Gutry:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Graphite Bio, Inc. CHIEF BUSINESS OFFICER Common Stock 300K $1.22M $4.08 Apr 11, 2022 Direct
Avalo Therapeutics, Inc. Director Stock Option (Right to Buy) 4.72K Sep 30, 2021 Direct

Insider Reports Filed by Phil Gutry

Symbol Company Period Transactions Value $ Form Type Date Filed Role
GRPH Graphite Bio, Inc. Apr 11, 2022 1 $20.1K 4 Apr 13, 2022 CHIEF BUSINESS OFFICER
GRPH Graphite Bio, Inc. Feb 16, 2022 1 $0 4 Feb 18, 2022 CHIEF BUSINESS OFFICER
AVTX Avalo Therapeutics, Inc. Dec 1, 2021 0 $0 4 Dec 3, 2021 Director
AVTX Avalo Therapeutics, Inc. Sep 30, 2021 1 $0 4 Oct 4, 2021 Director
AVTX Cerecor Inc. Jun 30, 2021 1 $0 4 Jul 2, 2021 Director
GRPH Graphite Bio, Inc. Jun 24, 2021 0 $0 3 Jun 24, 2021 CHIEF BUSINESS OFFICER
AVTX Cerecor Inc. Jun 15, 2021 1 $0 4 Jun 17, 2021 Director
GRPH Graphite Bio, Inc. Jan 13, 2021 10 $148K 4 Jul 1, 2021 CHIEF BUSINESS OFFICER